Biological Weapons Convention

US Marine Corps practice responding to weapons of mass destruction scenarios.

Could the bioweapons treaty be another tool for addressing pandemics?

By Daniel Gerstein | Disruptive Technologies, Uncategorized

Soldiers practice responding to a chemical or biological weapons attack.

How Russia worked to undermine UN bioweapons investigations

By Filippa Lentzos, Jez Littlewood | Chemical Weapons

A screen shot of the AMY1 gene from Arabidopsis thaliana, a small flowering plant widely used as a model organism in plant biology. (US government photo)

How to protect the world from ultra-targeted biological weapons

By Filippa Lentzos | Biosecurity, Cyber Security, Disruptive Technologies, Synthetic biology

A disease detective during the 2014 Ebola outbreak in Liberia.

Scientists are working on vaccines that spread like a disease. What could possibly go wrong?

By Filippa Lentzos, Guy Reeves | Biosecurity

Representatives to the Biological Weapons Convention meet.

Twenty-first century perspectives on the Biological Weapon Convention: Continued relevance or toothless paper tiger

By Glenn Cross, Lynn Klotz | Biosecurity

Julian Perry Robinson

Julian Perry Robinson, top chemical and biological arms control expert, dies of coronavirus

By Nicholas A. Sims | Biosecurity

A health care worker in China waits for a coronavirus patient.

Trump touts biodefense strategy but slashes funding to detect and combat outbreaks like coronavirus

By Matt Field | Biosecurity, Disruptive Technologies

The building housing smallpox-causing virus at the VECTOR research center.

What happened after an explosion at a Russian disease research lab called VECTOR?

By Filippa Lentzos | Analysis, Biosecurity

Soldier donning a gas mask.

The Biological Weapons Convention protocol should be revisited

By Lynn Klotz | Biosecurity, Opinion

Illustration by Matt Field.

Laboratories in the cloud

By Filippa Lentzos, Cédric Invernizzi | Biosecurity, Disruptive Technologies, Synthetic biology

Will splashy philanthropy cause the biosecurity field to focus on the wrong risks?

By Filippa Lentzos | Biosecurity, Columnists

Making sense of the 2018 National Biodefense Strategy

By Rachel Bartholomew, Kristin Omberg | Biosecurity, Disruptive Technologies, Opinion

Join us for the Bulletin's annual gathering on November 12